chr16-11254998-T-TGCGGC
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_003745.2(SOCS1):c.476_480dupGCCGC(p.Met161fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000141 in 1,415,538 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
SOCS1
NM_003745.2 frameshift
NM_003745.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.683
Genes affected
SOCS1 (HGNC:19383): (suppressor of cytokine signaling 1) This gene encodes a member of the STAT-induced STAT inhibitor (SSI), also known as suppressor of cytokine signaling (SOCS), family. SSI family members are cytokine-inducible negative regulators of cytokine signaling. The expression of this gene can be induced by a subset of cytokines, including IL2, IL3 erythropoietin (EPO), CSF2/GM-CSF, and interferon (IFN)-gamma. The protein encoded by this gene functions downstream of cytokine receptors, and takes part in a negative feedback loop to attenuate cytokine signaling. Knockout studies in mice suggested the role of this gene as a modulator of IFN-gamma action, which is required for normal postnatal growth and survival. [provided by RefSeq, Jul 2008]
RMI2 (HGNC:28349): (RecQ mediated genome instability 2) RMI2 is a component of the BLM (RECQL3; MIM 604610) complex, which plays a role in homologous recombination-dependent DNA repair and is essential for genome stability (Xu et al., 2008 [PubMed 18923082]).[supplied by OMIM, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.245 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-11254998-T-TGCGGC is Pathogenic according to our data. Variant chr16-11254998-T-TGCGGC is described in ClinVar as [Pathogenic]. Clinvar id is 977214.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SOCS1 | NM_003745.2 | c.476_480dupGCCGC | p.Met161fs | frameshift_variant | 2/2 | ENST00000332029.4 | NP_003736.1 | |
LOC105371082 | XR_933070.4 | n.178+5228_178+5232dupGGCGC | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SOCS1 | ENST00000332029.4 | c.476_480dupGCCGC | p.Met161fs | frameshift_variant | 2/2 | 1 | NM_003745.2 | ENSP00000329418.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.00000557 AC: 1AN: 179392Hom.: 0 AF XY: 0.00000996 AC XY: 1AN XY: 100392
GnomAD3 exomes
AF:
AC:
1
AN:
179392
Hom.:
AF XY:
AC XY:
1
AN XY:
100392
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000141 AC: 2AN: 1415538Hom.: 0 Cov.: 32 AF XY: 0.00000142 AC XY: 1AN XY: 702468
GnomAD4 exome
AF:
AC:
2
AN:
1415538
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
702468
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Autoimmune hemolytic anemia;C0242584:Autoimmune thrombocytopenia Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | Immunogenetics of Pediatric Autoimmune Diseases, Institut Imagine | Jan 01, 2020 | - - |
Autoinflammatory syndrome with immunodeficiency Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Department of Immunology, Beijing Children's Hospital of Capital Medical University | Jan 08, 2022 | The SOCS1 c.480_481insGCCGC (p.M161Afs*46) variant is classified as pathogenic based on it being a frameshift insertion predicted to result in a truncated or absent protein (PVS1), its rarity in population databases (PM2_Supporting), and published literature and ClinVar entries supporting its role in autoimmune disease (PS4). This variant is associated with autosomal dominant Autoimmune inflammatory syndrome, familial, with or without immunodeficiency (OMIM: 619375), which is characterized by a variety of autoimmune features. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at